Back To Schedule
Tuesday, June 20 • 8:00am - 9:30am
#201: Paying for Value in Biopharmaceuticals: Trends in the United States

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
Component Type: Session
Level: Intermediate
CE: ACPE 1.50 Knowledge UAN: 0286-0000-17-563-L04-P; CME 1.50; IACET 1.50; RN 1.50

Recent political and media attention has focused on the cost of medicines, with U.S. politicians and some consumer organizations demanding lower prices, as well as more transparency around pricing that all too frequently seems opaque. At the same time, U.S. health care is transitioning to focus more on paying for the value of care provided, rather than on the volume of goods and services, including for drugs. This DIAmond session will provide context on how drug pricing, reimbursement, and purchasing decisions are evolving in the US. Topics to be explored include how U.S. biopharmaceutical prices are determined in contrast to other countries; the roles of different players, such as pharmacy benefit managers, in the system; and how payers and manufacturers are embracing new value-based arrangements to make more efficient and effective use of the dollars spent on biopharmaceuticals.

Learning Objectives

Discuss the decision making process for drug pricing, reimbursement, and access to medicines; Define value and its impact on health care spending


Sudip Parikh, PhD


Sloane Salzburg, MS

Shawn Davis

Joel Beetsch, PhD

Phillip J. Lerner, MD, MPH

avatar for Joel Beetsch

Joel Beetsch

Vice President, Global Patient Advocacy, Celgene Corporation
Dr. Beetsch, VP of Patient Advocacy in Celgene’s Corporate Affairs Dept., leads the global development & execution of a coordinated patient-focused Advocacy strategy working w/multiple patient, provider, payer, & policy organizations around the world to foster safe & effective solutions... Read More →
avatar for Shawn Davis

Shawn Davis

Senior Director, Formulary Solutions, Express Scripts
Shawn helps Express Scripts’ clients improve patient’s health while reducing costs by developing solutions to deliver complex, life-saving medications at sustainable prices. His responsibilities include: Chairing the Value Assessment Committee to develop the Express Scripts... Read More →
avatar for Phillip Lerner

Phillip Lerner

Vice President and National Medical Director, Aetna, Inc.
Dr. Phil Lerner is Vice President and National Medical Director at Aetna. He is the Head of Condition Analysis and leads multiple clinical teams that analyze claims data and develop strategies to help Aetna members receive evidence based cost effective health care. He also leads Aetna’s... Read More →
avatar for Sudip Parikh

Sudip Parikh

Senior Vice President and Managing Director, DIA Americas, DIA
Sudip S. Parikh, PhD, serves as Senior Vice President and Managing Director for DIA Americas. He previously served as Vice President and General Manager of Health & Consumer Solutions at Battelle, leading its Healthcare Improvement, Public Health Research, and Consumer, Industrial... Read More →
avatar for Sloane Salzburg

Sloane Salzburg

Executive Director, Prescriptions For A Healthy America
Sloane Salzburg is Vice President for the Council for Affordable Health Coverage (CAHC) and Executive Director of CAHC's 50-organization campaign, called Prescriptions for a Healthy America (P4HA). P4HA works to raise awareness of the growing challenges posed by medication nonadherence... Read More →

Tuesday June 20, 2017 8:00am - 9:30am CDT
S105 McCormick Place 2301 South Martin Luther King Jr. Drive, Gate 4 Chicago, IL 60616
  12: DIAmond, Session
  • format json
  • Featured Topics Real World Evidence,Public Policy,StudentProgramming
  • Credit Type ACPE, CME, IACET, RN
  • Tags Session